Published in J Bacteriol on September 01, 1979
PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother (1995) 12.54
Characterization of the nonenzymatic chloramphenicol resistance (cmlA) gene of the In4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J Bacteriol (1991) 3.53
Respiratory epithelial cell invasion by group B streptococci. Infect Immun (1992) 2.86
Transposons Tn1696 and Tn21 and their integrons In4 and In2 have independent origins. Antimicrob Agents Chemother (2001) 2.70
Ribosome regulation by the nascent peptide. Microbiol Rev (1996) 2.41
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.78
Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons. J Bacteriol (1990) 1.60
Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57
Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J Bacteriol (1979) 1.44
Anti-peptidyl transferase leader peptides of attenuation-regulated chloramphenicol-resistance genes. Proc Natl Acad Sci U S A (1994) 1.36
Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting gram-negative bacteria and its use in molecular epidemiology. Antimicrob Agents Chemother (2001) 1.35
Tn292l, a transposon encoding fosfomycin resistance. J Bacteriol (1982) 1.20
Antibiotic resistance in Providencia stuartii isolated in hospitals. J Clin Microbiol (1981) 1.18
Comparison of three DNA hybridization methods for detection of the aminoglycoside 2"-O-adenylyltransferase gene in clinical bacterial isolates. Antimicrob Agents Chemother (1985) 1.09
Tn2001, a transposon encoding chloramphenicol resistance in Pseudomonas aeruginosa. J Bacteriol (1981) 1.07
A class 1 integron present in a human commensal has a hybrid transposition module compared to Tn402: evidence of interaction with mobile DNA from natural environments. J Bacteriol (2008) 1.01
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Pseudomonas streptomycin resistance transposon associated with R-plasmid mobilization. J Bacteriol (1983) 0.75
Chloramphenicol transposons found in Salmonella naestved and Escherichia coli of domestic animal origin. Antimicrob Agents Chemother (1981) 0.75
Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A (1972) 57.06
Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J Bacteriol (1976) 43.93
Pedigrees of some mutant strains of Escherichia coli K-12. Bacteriol Rev (1972) 35.97
Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol (1975) 16.73
A simple method for the preparation of large quantities of pure plasmid DNA. Biochim Biophys Acta (1975) 15.28
Isolation of an E. coli strain with a mutation affecting DNA polymerase. Nature (1969) 12.96
Construction and characterization of new cloning vehicles. I. Ampicillin-resistant derivatives of the plasmid pMB9. Gene (1977) 12.93
The transposon Tn1 as a probe for studying ColE1 structure and function. Mol Gen Genet (1977) 8.71
Deletions affecting the transposition of an antibiotic resistance gene. Proc Natl Acad Sci U S A (1977) 5.48
Transposition of a plasmid deoxyribonucleic acid sequence that mediates ampicillin resistance: independence from host rec functions and orientation of insertion. J Bacteriol (1976) 4.13
Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groups. Can J Microbiol (1975) 1.79
Recombination between plasmids of incompatibility groups P-1 and P-2. J Bacteriol (1976) 1.79
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. J Infect Dis (1976) 1.72
Method for the genetic labeling of cryptic plasmids. J Bacteriol (1978) 1.69
Common plasmid specifying tobramycin resistance found in two enteric bacteria isolated from burn patients. Antimicrob Agents Chemother (1978) 1.23
A molecular analysis of transductional marker rescue involving P-group plasmids in Pseudomonas aeruginosa. Mol Gen Genet (1976) 1.18
beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens. J Infect Dis (1976) 1.05
Third type of plasmid conferring gentamicin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1975) 1.02
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1974) 3.35
Cephalosporinase activity in Bacteroides fragilis. Antimicrob Agents Chemother (1973) 3.27
Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun (1997) 2.97
Vancomycin revisited. Ann Intern Med (1978) 2.86
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin. Antimicrob Agents Chemother (1972) 2.80
A case-control study of necrotizing fasciitis during primary varicella. Pediatrics (1999) 2.54
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol (2000) 2.45
Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol (2001) 2.28
Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun (1996) 2.25
Transfer of ampicillin resistance between strains of Haemophilus influenzae type B. J Infect Dis (1975) 2.21
Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J Infect Dis (1981) 2.13
Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A (1989) 2.13
Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J (1995) 2.04
New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol (1997) 2.04
Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun (1993) 2.01
Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene (1998) 1.87
Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis (1988) 1.82
Erysipelothrix rhusiopathiae: an occupational pathogen. Clin Microbiol Rev (1989) 1.74
A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73
Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol (2000) 1.69
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis (1992) 1.68
Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins. J Infect Dis (1976) 1.64
Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun (1994) 1.63
Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun (1993) 1.63
Group B streptococci adhere to a variant of fibronectin attached to a solid phase. Mol Microbiol (1995) 1.63
Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun (1992) 1.56
Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother (1975) 1.56
Molecular analysis of plasmids in epidemiologic investigation. J Infect Dis (1983) 1.54
Bacteremia and infection of a hip prosthesis caused by Bacillus alvei. J Clin Microbiol (1989) 1.53
The essential role of the liver in detoxification of endotoxin. Ann N Y Acad Sci (1966) 1.53
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun (2000) 1.52
Antibiotic resistance in developing countries. J Infect Dis (1985) 1.51
Activity of penicillinase in Staphylococcus aureus as studied by the iodometric method. J Infect Dis (1970) 1.48
Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis (1981) 1.45
Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens. Antimicrob Agents Chemother (1982) 1.44
Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J Bacteriol (1979) 1.44
Genetic loci of Streptococcus mitis that mediate binding to human platelets. Infect Immun (2001) 1.38
Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun (1989) 1.38
Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob Agents Chemother (1975) 1.38
Enteritis and coliform bacteremia in guinea pigs given penicillin. Am J Pathol (1965) 1.30
Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res (1999) 1.26
Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Mol Microbiol (2005) 1.22
Interbacterial transfer of R factor in the human intestine: in-vivo acquisition of R-factor-mediated kanamycin resistance by a multiresistant strain of Shigella sonnei. J Infect Dis (1972) 1.21
Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun (1998) 1.19
Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr (1993) 1.18
Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. Am J Med (1981) 1.18
Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J (1996) 1.13
The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis (1992) 1.13
Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol (1996) 1.10
A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis (1997) 1.09
Antibiotic resistance in Shigella mediated by R factors. J Infect Dis (1971) 1.08
Tranferable antibiotic resistance associated with an outbreak of shigellosis. Ann Intern Med (1967) 1.06
NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1. FEMS Microbiol Lett (2000) 1.06
Use of a dental amalgamator to extract RNA from the gram-positive bacterium Streptococcus agalactiae. Biotechniques (1997) 1.06
Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol (2005) 1.06
beta-Lactamase activity in Chromobacterium violaceum. J Infect Dis (1976) 1.06
beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens. J Infect Dis (1976) 1.05
Reversible neutropenia from vancomycin. JAMA (1979) 1.03
Comparative beta-lactamase resistance and antistaphylococcal activities of parenterally and orally administered cephalosporins. J Infect Dis (1978) 1.03
Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03
Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis (2000) 1.01
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest (1998) 0.99
Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother (1980) 0.99
Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics. Ann Intern Med (1967) 0.98
Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun (1987) 0.97
Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli. Antimicrob Agents Chemother (1973) 0.96
R factors in strains of Shigella dysenteriae type 1 isolated in the western hemisphere during 1969-1970. J Infect Dis (1971) 0.95
Use of nonhuman primate models to investigate mechanisms of infection-associated preterm birth. BJOG (2010) 0.94
Hemorrhagic cystitis and ureteritis, and interstitial nephritis associated with administration of penicillin G. J Urol (1979) 0.94
Attempted transfer of antibiotic resistance between Bacteroides and Escherichia coli. J Gen Microbiol (1976) 0.94
Rothia dentocariosa endocarditis complicated by perivalvular abscess. Clin Infect Dis (1993) 0.94
The role of group B streptococci beta-hemolysin expression in newborn lung injury. Adv Exp Med Biol (1997) 0.94
Analysis of the capsule synthesis locus, a virulence factor in group B streptococci. Adv Exp Med Biol (1997) 0.94
R factor-mediated antibiotic resistance in Serratia marcescens. Antimicrob Agents Chemother (1976) 0.93
Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J (2009) 0.93
Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients. Am J Clin Pathol (1984) 0.92
Characterization of Enterococcus faecalis alkaline phosphatase and use in identifying Streptococcus agalactiae secreted proteins. J Bacteriol (1999) 0.91
Modification of antibiotic resistance in gram-negative bacteria by penicillinase inhibition. Antimicrob Agents Chemother (Bethesda) (1966) 0.88
Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci (1980) 0.88
Antimicrobial resistance and R factors in Salmonella isolated from humans and animals in Georgia and South Carolina. South Med J (1977) 0.87
Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun (1995) 0.87
Gentamicin transposons. J Antimicrob Chemother (1980) 0.85
Antibiotic resistance in intestinal bacteria. Clin Gastroenterol (1979) 0.85
Susceptibility of rabbits to pyrogenic and lethal effects of endotoxin after acute liver injury. Proc Soc Exp Biol Med (1968) 0.84
Antimicrobial therapy of infections due to anaerobic bacteria. Semin Drug Treat (1972) 0.84
Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli. Am J Clin Pathol (1976) 0.84
Genetic properties of R factors associated with epidemic strains of Shigella dysenteriae type I from Central America and Salmonella typhi from Mexico. J Infect Dis (1973) 0.84
NSAIDS and necrotizing fasciitis. Pediatr Infect Dis J (1999) 0.83
Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets. Pediatr Res (1989) 0.83
Bacterial evasion of the antibody response: human IgG antibodies neutralize soluble but not bacteria-associated group B streptococcal C5a-ase. J Infect Dis (1992) 0.81
Tumor necrosis factor-alpha and interleukin-1alpha decrease the adherence of Streptococcus pyogenes to cultured keratinocytes. J Infect Dis (1999) 0.81
Plasmids and antibiotic resistance in gram-negative bacteria. J S C Med Assoc (1980) 0.80
Superinfection compatibility of R factors in Shigella dysenteriae type 1 from Central America and Salmonella typhi from Mexico. J Infect Dis (1974) 0.80